United States Biotechnology & Medical Research

Tyra Biosciences Inc (TYRA)

Track

Over the past 90 days, Tyra Biosciences Inc. has seen three insider transactions, all involving sales. Notably, major shareholder Nextech VI Oncology SCSP executed significant proposed sales totaling nearly $20 million. These transactions occurred following the company's recent earnings report, which showed an EPS miss, amid a 12.6% decline in stock price over the same period.
Ticker: TYRA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tyra Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 26 Jun 2026
Value US$2,270,774.73 | Price 432.78 | Shares 18,854
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-26 2026-06-26 PrS Proposed sale
NEXTECH VI ONCOLOGY SCSP

Shareholder
18,854
432.78
US$2,270,775 		18,854 432.78 US$2,270,775
2026-06-01 2026-06-01 PrS Proposed sale
NEXTECH VI ONCOLOGY SCSP

Shareholder
61,532
319.74
US$3,976,419 		61,532 319.74 US$3,976,419
2026-05-12 2026-05-12 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
18,101
294.92
US$979,042 		18,101 294.92 US$979,042
2026-04-13 2026-04-13 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
8,000
35.63
US$285,000 		8,000 35.63 US$285,000
2026-03-26 2026-03-26 PrS Proposed sale
2.0
GILLA KAPLAN

Director

Non-Executive Director
53,172
37.75
US$2,007,153 		53,172 37.75 US$2,007,153
2026-03-27 2026-03-25 S Sale
2.0
KAPLAN GILLA
Non-Executive Director
14,295 -33.6%
36.97
US$528,506 		14,295 -33.6% 36.97 US$528,506
2026-03-25 2026-03-25 PrS Proposed sale
2.0
GILLA KAPLAN

Director

Non-Executive Director
14,295
36.97
US$528,506 		14,295 36.97 US$528,506
2026-03-12 2026-03-12 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
8,000
35.38
US$283,000 		8,000 35.38 US$283,000
2026-02-13 2026-02-12 PlS Planned sale
3.2
Bensen Daniel

Chief Discovery Officer

Officer
5,872 -3.8%
33.37
US$195,929 		5,872 -3.8% 33.37 US$195,929
2026-02-13 2026-02-12 PlS Planned sale
3.2
Bensen Daniel

Chief Discovery Officer

Officer
2,128 -1.4%
31.50
US$67,036 		2,128 -1.4% 31.50 US$67,036
2026-02-12 2026-02-12 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
8,000
32.75
US$262,000 		8,000 32.75 US$262,000
2026-01-20 2026-01-12 PlS Planned sale
3.2
Bensen Daniel

Chief Discovery Officer

Officer
1,017 -0.7%
29.08
US$29,575 		1,017 -0.7% 29.08 US$29,575
2026-01-20 2026-01-12 PlS Planned sale
3.2
Bensen Daniel

Chief Discovery Officer

Officer
6,983 -4.3%
28.44
US$198,610 		6,983 -4.3% 28.44 US$198,610
2026-01-12 2026-01-12 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
8,000
29.00
US$232,000 		8,000 29.00 US$232,000
2025-12-19 2025-12-19 PlS Planned sale
2.8
MORE ROBERT J
Non-Executive Director
10,000 -0.3%
25.00
US$250,000 		10,000 -0.3% 25.00 US$250,000
2025-12-16 2025-12-12 PlS Planned sale
3.2
Bensen Daniel

Chief Discovery Officer

Officer
8,000 -4.7%
22.64
US$181,159 		8,000 -4.7% 22.64 US$181,159
2025-12-12 2025-12-12 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
8,000
22.50
US$180,000 		8,000 22.50 US$180,000
2025-11-25 2025-11-21 PlS Planned sale
2.8
MORE ROBERT J
Non-Executive Director
246,871 -6.1%
20.25
US$5,000,026 		246,871 -6.1% 20.25 US$5,000,026
2025-11-21 2025-11-21 PrS Proposed sale
Alta Partners NextGen Fund II, L.P.

Affiliate
256,871
21.00
US$5,394,291 		256,871 21.00 US$5,394,291
2025-11-19 2025-11-19 PlS Planned sale
3.2
Bensen Daniel

Chief Operating Officer

Officer
49,956 -22.6%
16.32
US$815,297 		49,956 -22.6% 16.32 US$815,297
2025-11-19 2025-11-18 PlS Planned sale
3.2
Bensen Daniel

Chief Operating Officer

Officer
75,633 -25.5%
16.07
US$1,215,627 		75,633 -25.5% 16.07 US$1,215,627
2025-11-18 2025-11-18 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
124,589
16.05
US$2,000,000 		124,589 16.05 US$2,000,000
2025-11-17 2025-11-17 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
20,072
15.94
US$320,000 		20,072 15.94 US$320,000
2025-11-17 2025-11-17 PlS Planned sale
3.2
Bensen Daniel

Chief Operating Officer

Officer
1,500 -0.5%
17.07
US$25,607 		1,500 -0.5% 17.07 US$25,607
2025-11-17 2025-11-17 PlS Planned sale
3.2
Bensen Daniel

Chief Operating Officer

Officer
18,572 -5.9%
16.11
US$299,191 		18,572 -5.9% 16.11 US$299,191
2025-11-17 2025-11-14 PlS Planned sale
3.2
Bensen Daniel

Chief Operating Officer

Officer
110,228 -25.8%
16.02
US$1,765,489 		110,228 -25.8% 16.02 US$1,765,489
2025-11-14 2025-11-14 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
86,339
15.98
US$1,380,000 		86,339 15.98 US$1,380,000
2025-11-17 2025-11-13 PlS Planned sale
3.2
Bensen Daniel

Chief Operating Officer

Officer
1,111 -0.3%
16.00
US$17,780 		1,111 -0.3% 16.00 US$17,780
2025-11-13 2025-11-13 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
25,000
16.00
US$400,000 		25,000 16.00 US$400,000
2025-06-20 2025-06-18 S Sale
2.0
KAPLAN GILLA
Non-Executive Director
9,568 -25.3%
9.78
US$93,596 		9,568 -25.3% 9.78 US$93,596
2025-06-18 2025-06-18 PrS Proposed sale
2.0
GILLA KAPLAN

Director

Non-Executive Director
9,568
9.78
US$93,596 		9,568 9.78 US$93,596
2025-06-20 2025-06-17 S Sale
2.0
KAPLAN GILLA
Non-Executive Director
10 -0.0%
10.35
US$104 		10 -0.0% 10.35 US$104
2025-06-17 2025-06-17 PrS Proposed sale
2.0
GILLA KAPLAN

Director

Non-Executive Director
10
10.35
US$104 		10 10.35 US$104
2025-06-16 2025-06-16 PrS Proposed sale
2.0
GILLA KAPLAN

Director

Non-Executive Director
6,814
10.38
US$70,726 		6,814 10.38 US$70,726
2025-06-16 2025-06-16 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
11,813 +0.1%
10.13
US$119,666 		11,813 +0.1% 10.13 US$119,666
2025-06-16 2025-06-16 S Sale
2.0
KAPLAN GILLA
Non-Executive Director
6,814 -15.3%
10.38
US$70,726 		6,814 -15.3% 10.38 US$70,726
2025-06-16 2025-06-13 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
120,167 +1.2%
10.20
US$1,225,703 		120,167 +1.2% 10.20 US$1,225,703
2025-06-16 2025-06-13 S Sale
2.0
KAPLAN GILLA
Non-Executive Director
15,000 -25.2%
10.31
US$154,582 		15,000 -25.2% 10.31 US$154,582
2025-06-13 2025-06-13 PrS Proposed sale
2.0
GILLA KAPLAN

Director

Non-Executive Director
15,000
10.31
US$154,582 		15,000 10.31 US$154,582
2025-06-16 2025-06-12 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
31,307 +0.3%
10.20
US$319,331 		31,307 +0.3% 10.20 US$319,331
2025-06-16 2025-06-12 S Sale
2.0
KAPLAN GILLA
Non-Executive Director
30,000 -33.5%
10.31
US$309,255 		30,000 -33.5% 10.31 US$309,255
2025-06-12 2025-06-12 PrS Proposed sale
2.0
GILLA KAPLAN

Director

Non-Executive Director
30,000
10.31
US$309,255 		30,000 10.31 US$309,255
2025-06-11 2025-06-09 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
186,850 +1.9%
10.19
US$1,904,002 		186,850 +1.9% 10.19 US$1,904,002
2025-06-06 2025-06-05 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
213,334 +2.2%
10.04
US$2,141,873 		213,334 +2.2% 10.04 US$2,141,873
2025-06-06 2025-06-04 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
997,864 +11.5%
9.63
US$9,609,430 		997,864 +11.5% 9.63 US$9,609,430
2025-02-07 2025-02-05 S Sale
4.0
Kjellson Nina S
Non-Executive Director
3,511 -0.8%
13.76
US$48,315 		3,511 -0.8% 13.76 US$48,315
2025-02-07 2025-02-05 S Sale
4.0
Kjellson Nina S
Non-Executive Director
1,890 -0.1%
13.76
US$26,008 		1,890 -0.1% 13.76 US$26,008
2025-02-05 2025-02-05 PrS Proposed sale
2.0
Canaan XI, LP

Director

Non-Executive Director
120,000
13.75
US$1,650,000 		120,000 13.75 US$1,650,000
2025-02-05 2025-02-05 PrS Proposed sale
Canaan 2020 Plus Co-Investment LP - Series 7

Director

Non-Executive Director
112,500
13.75
US$1,546,875 		112,500 13.75 US$1,546,875
2025-01-27 2025-01-23 S Sale
4.0
Kjellson Nina S
Non-Executive Director
4,825 -0.1%
16.26
US$78,466 		4,825 -0.1% 16.26 US$78,466
2025-01-22 2025-01-22 PrS Proposed sale
Subramony Siddarth

Director

Non-Executive Director
18,597
15.71
US$292,236 		18,597 15.71 US$292,236
2025-01-21 2025-01-21 S Sale
4.0
Kjellson Nina S
Non-Executive Director
3,993 -0.1%
16.36
US$65,336 		3,993 -0.1% 16.36 US$65,336
2025-01-21 2025-01-17 S Sale
4.0
Kjellson Nina S
Non-Executive Director
461 -0.1%
16.40
US$7,560 		461 -0.1% 16.40 US$7,560
2025-01-21 2025-01-17 S Sale
4.0
Kjellson Nina S
Non-Executive Director
12,808 -0.3%
16.40
US$210,052 		12,808 -0.3% 16.40 US$210,052
2025-01-21 2025-01-16 S Sale
4.0
Kjellson Nina S
Non-Executive Director
835 -0.2%
16.29
US$13,600 		835 -0.2% 16.29 US$13,600
2025-01-21 2025-01-16 S Sale
4.0
Kjellson Nina S
Non-Executive Director
6,944 -0.2%
16.29
US$113,097 		6,944 -0.2% 16.29 US$113,097
2024-12-09 2024-12-09 PrS Proposed sale
Tada Hiroomi

Officer

Officer
10,000
15.90
US$159,000 		10,000 15.90 US$159,000
2024-12-05 2024-12-05 PrS Proposed sale
Tada Hiroomi

Officer

Officer
5,000
15.00
US$75,000 		5,000 15.00 US$75,000
2024-12-02 2024-12-02 PrS Proposed sale
Tada Hiroomi

Officer

Officer
5,000
16.00
US$80,000 		5,000 16.00 US$80,000
2024-11-26 2024-11-25 S Sale
4.0
Kjellson Nina S
Non-Executive Director
566 -0.1%
16.84
US$9,531 		566 -0.1% 16.84 US$9,531
2024-11-26 2024-11-25 S Sale
4.0
Kjellson Nina S
Non-Executive Director
4,706 -0.1%
16.84
US$79,242 		4,706 -0.1% 16.84 US$79,242
2024-11-20 2024-11-20 PrS Proposed sale
Tada Hiroomi

Officer

Officer
10,000
15.47
US$154,700 		10,000 15.47 US$154,700
2024-11-14 2024-11-14 PrS Proposed sale
Tada Hiroomi

Officer

Officer
10,107
15.94
US$161,106 		10,107 15.94 US$161,106
2024-11-13 2024-11-08 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,220,681 +16.3%
16.25
US$19,836,066 		1,220,681 +16.3% 16.25 US$19,836,066
2024-11-08 2024-11-07 S Sale
4.0
Kjellson Nina S
Non-Executive Director
2,371 -0.5%
17.32
US$41,061 		2,371 -0.5% 17.32 US$41,061
2024-11-08 2024-11-07 S Sale
4.0
Kjellson Nina S
Non-Executive Director
19,720 -0.5%
17.32
US$341,513 		19,720 -0.5% 17.32 US$341,513
2024-11-08 2024-11-06 S Sale
4.0
Kjellson Nina S
Non-Executive Director
5,635 -1.2%
17.18
US$96,784 		5,635 -1.2% 17.18 US$96,784
2024-11-08 2024-11-06 S Sale
4.0
Kjellson Nina S
Non-Executive Director
46,856 -1.2%
17.18
US$804,775 		46,856 -1.2% 17.18 US$804,775
2024-11-06 2024-11-05 S Sale
4.0
Kjellson Nina S
Non-Executive Director
1,126 -0.2%
16.77
US$18,881 		1,126 -0.2% 16.77 US$18,881
2024-11-06 2024-11-05 S Sale
4.0
Kjellson Nina S
Non-Executive Director
9,367 -0.2%
16.77
US$157,069 		9,367 -0.2% 16.77 US$157,069
2024-11-06 2024-11-04 S Sale
4.0
Kjellson Nina S
Non-Executive Director
116 -0.0%
17.01
US$1,973 		116 -0.0% 17.01 US$1,973
2024-11-06 2024-11-04 S Sale
4.0
Kjellson Nina S
Non-Executive Director
960 -0.0%
17.01
US$16,326 		960 -0.0% 17.01 US$16,326
2024-11-01 2024-11-01 S Sale
4.0
Kjellson Nina S
Non-Executive Director
73 -0.0%
17.16
US$1,253 		73 -0.0% 17.16 US$1,253
2024-11-01 2024-11-01 S Sale
4.0
Kjellson Nina S
Non-Executive Director
2,878 -0.6%
16.54
US$47,615 		2,878 -0.6% 16.54 US$47,615
2024-11-01 2024-11-01 S Sale
4.0
Kjellson Nina S
Non-Executive Director
604 -0.0%
17.16
US$10,364 		604 -0.0% 17.16 US$10,364
Explore more

More insider trading research around Tyra Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America